Conditions: Asthma
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 421
Healthy volunteers: no

Brief summary:
This is a 3-week study to evaluate FEV1 following treatment with drugs in persistent asthma which is also active during allergy seasons in pediatric patients with seasonal aeroallergen sensitivity.

Detailed description:

Arms:
arm 1: montelukast arm 2: placebo

Interventions: intervention 1: montelukast sodium intervention 2: Comparator: Placebo
Intervention descriptions: intervention 1: montelukast 5 mg chewable tablet once daily. Up to 3 weeks of treatment. intervention 2: Placebo. Up to 3 weeks of treatment

Protocol document: